空間ゲノミクスとトランスクリプトミクスの世界市場レポート 2025年

空間ゲノミクスとトランスクリプトミクス市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR12.4％で27億2,000万米ドルに成長します。予測期間中に予想される成長の原動力となるのは、疾患の早期発見ニーズの高まり、バイオマーカー探索の増加、先進診断薬に対する規制当局の支援、個別化医療の採用拡大、がん研究の継続的拡大などです。この期間に予想される主な動向には、シーケンス技術の向上、AIと機械学習の統合、革新的なデータ処理・可視化ツールの開発、データ保存・解析ソリューションの進歩、共同研究やコンソーシアムの増加などがあります。

個別化医療の採用拡大が、今後数年間の空間ゲノミクスとトランスクリプトミクス市場の成長を促進すると予想されます。個別化医療とは、遺伝的体質やライフスタイル、環境要因に基づいて患者一人ひとりに合った治療計画を立て、治療効果を高め、副作用を最小限に抑えるヘルスケアへのアプローチです。個別化医療に対する需要の高まりは、遺伝子研究の進歩に後押しされています。遺伝子研究の進歩により、個人固有の遺伝子プロファイルに合わせてカスタマイズされた、より精密な治療が可能になり、患者の予後改善につながります。情勢は、組織内の遺伝子の正確な位置と活性を特定することにより、個別化医療において重要な役割を果たします。例えば、2024年2月、米国の非営利団体である個別化医療連合（Personalized Medicine Coalition）は、2023年にFDAが希少疾患患者のために16の新しい個別化治療を承認したと報告しました。その結果、個別化医療の採用が増加し、空間ゲノミクスとトランスクリプトミクス市場の成長を牽引しています。

空間ゲノミクスとトランスクリプトミクス市場の主要企業は、空間トランスクリプトミクス技術などの革新的ソリューションの開発に注力し、組織構造の文脈における遺伝子発現の理解を深めています。空間トランスクリプトミクスとは、組織サンプル全体の遺伝子発現を、その空間的コンテキストを維持しながらマッピングする高度な技術を指し、研究者は組織内のRNA分子の分布や位置を調査することができます。例えば、2025年2月、米国を拠点とするバイオテクノロジー企業であるイルミナ社は、複雑な組織内の遺伝子発現を細胞分解能でマッピングし解析する能力を大幅に向上させる、先駆的な空間トランスクリプトミクス技術を発表しました。このテクノロジーは、既存の方法よりも9倍広いキャプチャーエリアと4倍高い解像度を提供し、高感度で偏りのない全トランスクリプトームプロファイリングを可能にします。イルミナのNextSeqおよびNovaSeqシーケンサーと互換性があり、Illumina Connected Multiomicsプラットフォームに統合されているため、包括的なマルチオームデータ解析が容易になります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界空間ゲノミクスとトランスクリプトミクス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の空間ゲノミクスとトランスクリプトミクス市場：成長率分析
• 世界の空間ゲノミクスとトランスクリプトミクス市場の実績：規模と成長, 2019-2024
• 世界の空間ゲノミクスとトランスクリプトミクス市場の予測：規模と成長, 2024-2029, 2034F
• 世界空間ゲノミクスとトランスクリプトミクス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の空間ゲノミクスとトランスクリプトミクス市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 機器
• 消耗品
• ソフトウェア
• 世界の空間ゲノミクスとトランスクリプトミクス市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 空間トランスクリプトミクス
• シーケンスベースの方法
• 免疫組織化学（IHC）
• 顕微鏡ベースのRNAイメージング技術
• 空間ゲノミクス
• 世界の空間ゲノミクスとトランスクリプトミクス市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断
• 翻訳調査
• 医薬品の発見と開発
• 単一細胞解析
• 細胞生物学
• その他の用途
• 世界の空間ゲノミクスとトランスクリプトミクス市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬およびバイオテクノロジー企業
• 契約調査機関
• 学術研究機関
• 世界の空間ゲノミクスとトランスクリプトミクス市場、楽器の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• シーケンシングプラットフォーム
• イメージングシステム
• 蛍光顕微鏡
• スライドスキャナー
• フローサイトメーター
• 世界の空間ゲノミクスとトランスクリプトミクス市場消耗品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 試薬とキット
• スライドとカバーガラス
• プローブとタグ
• サンプル調製消耗品
• 世界の空間ゲノミクスとトランスクリプトミクス市場ソフトウェアの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• データ分析と可視化ツール
• 画像解析ソフトウェア
• ワークフロー管理ソフトウェア
• クラウドベースの分析プラットフォーム

第7章 地域別・国別分析

• 世界の空間ゲノミクスとトランスクリプトミクス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の空間ゲノミクスとトランスクリプトミクス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 空間ゲノミクスとトランスクリプトミクス市場：競合情勢
• 空間ゲノミクスとトランスクリプトミクス市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bio-Rad Laboratories Inc.
• Bruker Corporation
• Bio-Techne Corporation
• 10x Genomics Inc.
• Standard BioTools Inc.
• Akoya Biosciences Inc.
• Seven Bridges Genomics
• Vizgen Inc.
• Lunaphore Technologies SA.
• Parse Biosciences
• Indica Labs Inc.
• Resolve Biosciences GmbH.
• RareCyte Inc.
• Ionpath Inc.
• Dovetail Genomics

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 空間ゲノミクスとトランスクリプトミクス市場2029：新たな機会を提供する国
• 空間ゲノミクスとトランスクリプトミクス市場2029：新たな機会を提供するセグメント
• 空間ゲノミクスとトランスクリプトミクス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Spatial genomics and transcriptomics encompass techniques that map the spatial distribution of gene expression and genetic information within tissues, enabling researchers to examine how cells interact within their native environments and contribute to biological processes or diseases. These methods offer high-resolution insights into gene activity at specific tissue locations, revealing cellular heterogeneity, disease mechanisms, and potential therapeutic targets.

The primary product types in spatial genomics and transcriptomics include instruments, consumables, and software. Instruments are devices or tools used for scientific research, including the investigation of natural phenomena and theoretical studies. These tools incorporate technologies such as spatial transcriptomics, sequencing-based methods, immunohistochemistry (IHC), microscopy-based RNA imaging techniques, and spatial genomics. They are applied in diagnostics, translational research, drug discovery and development, single-cell analysis, cell biology, and more. The main end users include pharmaceutical and biotechnology companies, contract research organizations, and academic and research institutes.

The spatial genomics and transcriptomics market research report is one of a series of new reports from The Business Research Company that provides spatial genomics and transcriptomics market statistics, including spatial genomics and transcriptomics industry global market size, regional shares, competitors with a spatial genomics and transcriptomics market share, detailed spatial genomics and transcriptomics market segments, market trends and opportunities, and any further data you may need to thrive in the spatial genomics and transcriptomics industry. This spatial genomics and transcriptomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The spatial genomics and transcriptomics market size has grown rapidly in recent years. It will grow from $1.51 billion in 2024 to $1.70 billion in 2025 at a compound annual growth rate (CAGR) of 12.7%. The growth during the historic period can be attributed to the emergence of single-cell genomics, increased funding for cancer research, expansion of bioinformatics infrastructure, rising demand for precision medicine, and advancements in pharmaceutical research and development.

The spatial genomics and transcriptomics market size is expected to see rapid growth in the next few years. It will grow to $2.72 billion in 2029 at a compound annual growth rate (CAGR) of 12.4%. The anticipated growth in the forecast period is driven by the increasing need for early disease detection, a rise in biomarker discovery, regulatory support for advanced diagnostics, growing adoption of personalized medicine, and continued expansion in cancer research. Key trends expected during this period include improvements in sequencing technologies, integration of AI and machine learning, development of innovative data processing and visualization tools, advancements in data storage and analysis solutions, and increased collaborations and consortia.

The growing adoption of personalized medicine is expected to drive the growth of the spatial genomics and transcriptomics market in the coming years. Personalized medicine is an approach to healthcare that tailors treatment plans to individual patients based on their genetic makeup, lifestyle, and environmental factors, enhancing treatment effectiveness and minimizing side effects. The increasing demand for personalized medicine is fueled by advancements in genetic research, which enable more precise treatments customized to an individual's unique genetic profile, leading to improved patient outcomes. Spatial genomics and transcriptomics play a key role in personalized medicine by identifying the precise location and activity of genes within tissues, allowing for targeted, individualized treatment strategies based on a patient's molecular landscape. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based nonprofit organization, reported that the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, a significant increase from the six approvals in 2022. As a result, the rising adoption of personalized medicine is driving the growth of the spatial genomics and transcriptomics market.

Leading companies in the spatial genomics and transcriptomics market are focusing on developing innovative solutions, such as spatial transcriptomics technologies, to deepen our understanding of gene expression in the context of tissue architecture. Spatial transcriptomics refers to advanced techniques that map gene expression across tissue samples while maintaining their spatial context, allowing researchers to study the distribution and location of RNA molecules within tissues. For instance, in February 2025, Illumina Inc., a U.S.-based biotechnology company, launched pioneering spatial transcriptomics technology that significantly enhances the ability to map and analyze gene expression within complex tissues at cellular resolution. This technology offers a capture area nine times larger and four times higher resolution than existing methods, enabling unbiased, whole-transcriptome profiling with high sensitivity. It is compatible with Illumina's NextSeq and NovaSeq sequencers and integrated into the Illumina Connected Multiomics platform, facilitating comprehensive multiomic data analysis.

In April 2024, Bruker Corporation, a U.S.-based manufacturer of scientific instruments and analytical solutions, acquired NanoString Technologies for an undisclosed amount. This acquisition aims to enhance Bruker's spatial biology portfolio by integrating NanoString's gene expression and spatial transcriptomics solutions. This move positions Bruker as a market leader, fostering innovation, revenue growth, and long-term value in the post-genomic era. NanoString Technologies is a U.S.-based biotechnology company specializing in spatial genomics and transcriptomics solutions.

Major players in the spatial genomics and transcriptomics market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Bio-Techne Corporation, 10x Genomics Inc., Standard BioTools Inc., Akoya Biosciences Inc., Seven Bridges Genomics, Vizgen Inc., Lunaphore Technologies SA., Parse Biosciences, Indica Labs Inc., Resolve Biosciences GmbH., RareCyte Inc., Ionpath Inc., Dovetail Genomics, S2 Genomics Inc., and BioSpyder Technologies Inc.

North America was the largest region in the spatial genomics and transcriptomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in spatial genomics and transcriptomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the spatial genomics and transcriptomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The spatial genomics and transcriptomics market includes revenues earned by entities by providing services such as spatial gene expression profiling, single-cell RNA sequencing, spatially resolved transcriptome analysis, cancer and disease research, and spatial epigenomics. The market value includes the value of related goods sold by the service provider or included within the service offering. The spatial genomics and transcriptomics market also includes sales of spatial transcriptomics platforms, imaging systems, and sequencing instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Spatial Genomics And Transcriptomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on spatial genomics and transcriptomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for spatial genomics and transcriptomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The spatial genomics and transcriptomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Instruments; Consumables; Software
• 2) By Technology: Spatial Transcriptomics; Sequencing-Based Methods; Immunohistochemistry (IHC); Microscopy-Based RNA Imaging Techniques; Spatial Genomics
• 3) By Application: Diagnostics; Translation Research; Drug Discovery And Development; Single Cell Analysis; Cell Biology; Other Applications
• 4) By End-User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Academic And Research Institutes
• Subsegments:
• 1) By Instruments: Sequencing Platforms; Imaging Systems; Fluorescence Microscopes; Slide Scanners; Flow Cytometers
• 2) By Consumables: Reagents And Kits; Slides And Coverslips; Probes And Tags; Sample Preparation Consumables
• 3) By Software: Data Analysis And Visualization Tools; Image Analysis Software; Workflow Management Software; Cloud-Based Analytics Platforms
• Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Agilent Technologies Inc.; Illumina Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Spatial Genomics And Transcriptomics Market Characteristics

3. Spatial Genomics And Transcriptomics Market Trends And Strategies

4. Spatial Genomics And Transcriptomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Spatial Genomics And Transcriptomics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Spatial Genomics And Transcriptomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Spatial Genomics And Transcriptomics Market Growth Rate Analysis
• 5.4. Global Spatial Genomics And Transcriptomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Spatial Genomics And Transcriptomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Spatial Genomics And Transcriptomics Total Addressable Market (TAM)

6. Spatial Genomics And Transcriptomics Market Segmentation

• 6.1. Global Spatial Genomics And Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments
• Consumables
• Software
• 6.2. Global Spatial Genomics And Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Spatial Transcriptomics
• Sequencing-Based Methods
• Immunohistochemistry (IHC)
• Microscopy-Based RNA Imaging Techniques
• Spatial Genomics
• 6.3. Global Spatial Genomics And Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostics
• Translation Research
• Drug Discovery And Development
• Single Cell Analysis
• Cell Biology
• Other Applications
• 6.4. Global Spatial Genomics And Transcriptomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Contract Research Organizations
• Academic And Research Institutes
• 6.5. Global Spatial Genomics And Transcriptomics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sequencing Platforms
• Imaging Systems
• Fluorescence Microscopes
• Slide Scanners
• Flow Cytometers
• 6.6. Global Spatial Genomics And Transcriptomics Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents And Kits
• Slides And Coverslips
• Probes And Tags
• Sample Preparation Consumables
• 6.7. Global Spatial Genomics And Transcriptomics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Analysis And Visualization Tools
• Image Analysis Software
• Workflow Management Software
• Cloud-Based Analytics Platforms

7. Spatial Genomics And Transcriptomics Market Regional And Country Analysis

• 7.1. Global Spatial Genomics And Transcriptomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Spatial Genomics And Transcriptomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Spatial Genomics And Transcriptomics Market

• 8.1. Asia-Pacific Spatial Genomics And Transcriptomics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Spatial Genomics And Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Spatial Genomics And Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Spatial Genomics And Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Spatial Genomics And Transcriptomics Market

• 9.1. China Spatial Genomics And Transcriptomics Market Overview
• 9.2. China Spatial Genomics And Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Spatial Genomics And Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Spatial Genomics And Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Spatial Genomics And Transcriptomics Market

• 10.1. India Spatial Genomics And Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Spatial Genomics And Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Spatial Genomics And Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Spatial Genomics And Transcriptomics Market

• 11.1. Japan Spatial Genomics And Transcriptomics Market Overview
• 11.2. Japan Spatial Genomics And Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Spatial Genomics And Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Spatial Genomics And Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Spatial Genomics And Transcriptomics Market

• 12.1. Australia Spatial Genomics And Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Spatial Genomics And Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Spatial Genomics And Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Spatial Genomics And Transcriptomics Market

• 13.1. Indonesia Spatial Genomics And Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Spatial Genomics And Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Spatial Genomics And Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Spatial Genomics And Transcriptomics Market

• 14.1. South Korea Spatial Genomics And Transcriptomics Market Overview
• 14.2. South Korea Spatial Genomics And Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Spatial Genomics And Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Spatial Genomics And Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Spatial Genomics And Transcriptomics Market

• 15.1. Western Europe Spatial Genomics And Transcriptomics Market Overview
• 15.2. Western Europe Spatial Genomics And Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Spatial Genomics And Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Spatial Genomics And Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Spatial Genomics And Transcriptomics Market

• 16.1. UK Spatial Genomics And Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Spatial Genomics And Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Spatial Genomics And Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Spatial Genomics And Transcriptomics Market

• 17.1. Germany Spatial Genomics And Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Spatial Genomics And Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Spatial Genomics And Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Spatial Genomics And Transcriptomics Market

• 18.1. France Spatial Genomics And Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Spatial Genomics And Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Spatial Genomics And Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Spatial Genomics And Transcriptomics Market

• 19.1. Italy Spatial Genomics And Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Spatial Genomics And Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Spatial Genomics And Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Spatial Genomics And Transcriptomics Market

• 20.1. Spain Spatial Genomics And Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Spatial Genomics And Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Spatial Genomics And Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Spatial Genomics And Transcriptomics Market

• 21.1. Eastern Europe Spatial Genomics And Transcriptomics Market Overview
• 21.2. Eastern Europe Spatial Genomics And Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Spatial Genomics And Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Spatial Genomics And Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Spatial Genomics And Transcriptomics Market

• 22.1. Russia Spatial Genomics And Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Spatial Genomics And Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Spatial Genomics And Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Spatial Genomics And Transcriptomics Market

• 23.1. North America Spatial Genomics And Transcriptomics Market Overview
• 23.2. North America Spatial Genomics And Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Spatial Genomics And Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Spatial Genomics And Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Spatial Genomics And Transcriptomics Market

• 24.1. USA Spatial Genomics And Transcriptomics Market Overview
• 24.2. USA Spatial Genomics And Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Spatial Genomics And Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Spatial Genomics And Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Spatial Genomics And Transcriptomics Market

• 25.1. Canada Spatial Genomics And Transcriptomics Market Overview
• 25.2. Canada Spatial Genomics And Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Spatial Genomics And Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Spatial Genomics And Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Spatial Genomics And Transcriptomics Market

• 26.1. South America Spatial Genomics And Transcriptomics Market Overview
• 26.2. South America Spatial Genomics And Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Spatial Genomics And Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Spatial Genomics And Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Spatial Genomics And Transcriptomics Market

• 27.1. Brazil Spatial Genomics And Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Spatial Genomics And Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Spatial Genomics And Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Spatial Genomics And Transcriptomics Market

• 28.1. Middle East Spatial Genomics And Transcriptomics Market Overview
• 28.2. Middle East Spatial Genomics And Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Spatial Genomics And Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Spatial Genomics And Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Spatial Genomics And Transcriptomics Market

• 29.1. Africa Spatial Genomics And Transcriptomics Market Overview
• 29.2. Africa Spatial Genomics And Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Spatial Genomics And Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Spatial Genomics And Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Spatial Genomics And Transcriptomics Market Competitive Landscape And Company Profiles

• 30.1. Spatial Genomics And Transcriptomics Market Competitive Landscape
• 30.2. Spatial Genomics And Transcriptomics Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Spatial Genomics And Transcriptomics Market Other Major And Innovative Companies

• 31.1. Bio-Rad Laboratories Inc.
• 31.2. Bruker Corporation
• 31.3. Bio-Techne Corporation
• 31.4. 10x Genomics Inc.
• 31.5. Standard BioTools Inc.
• 31.6. Akoya Biosciences Inc.
• 31.7. Seven Bridges Genomics
• 31.8. Vizgen Inc.
• 31.9. Lunaphore Technologies SA.
• 31.10. Parse Biosciences
• 31.11. Indica Labs Inc.
• 31.12. Resolve Biosciences GmbH.
• 31.13. RareCyte Inc.
• 31.14. Ionpath Inc.
• 31.15. Dovetail Genomics

32. Global Spatial Genomics And Transcriptomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Spatial Genomics And Transcriptomics Market

34. Recent Developments In The Spatial Genomics And Transcriptomics Market

35. Spatial Genomics And Transcriptomics Market High Potential Countries, Segments and Strategies

• 35.1 Spatial Genomics And Transcriptomics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Spatial Genomics And Transcriptomics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Spatial Genomics And Transcriptomics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer